David Rescott
Stock Analyst at Robert W. Baird
(3.82)
# 1,966
Out of 4,988 analysts
251
Total ratings
49.7%
Success rate
6.1%
Average return
Main Sectors:
Stocks Rated by David Rescott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Reiterated: Hold | $85 → $100 | $92.80 | +7.76% | 25 | Sep 2, 2026 | |
| HAE Haemonetics | Reiterated: Buy | $96 → $119 | $110.00 | +8.19% | 8 | Aug 21, 2026 | |
| IRTC iRhythm Holdings | Reiterated: Buy | $175 → $165 | $109.60 | +50.55% | 31 | Aug 7, 2026 | |
| RMD ResMed | Reiterated: Hold | $225 → $213 | $226.57 | -5.99% | 10 | Aug 7, 2026 | |
| PRCT PROCEPT BioRobotics | Reiterated: Hold | $28 → $20 | $19.34 | +3.41% | 3 | Aug 5, 2026 | |
| TMDX TransMedics Group | Reiterated: Buy | $140 → $122 | $86.83 | +40.50% | 8 | Aug 5, 2026 | |
| INSP Inspire Medical Systems | Reiterated: Hold | $50 → $59 | $75.69 | -22.05% | 20 | Aug 4, 2026 | |
| MMSI Merit Medical Systems | Reiterated: Buy | $83 → $98 | $85.52 | +14.59% | 14 | Jul 31, 2026 | |
| BSX Boston Scientific | Reiterated: Buy | $70 → $56 | $43.66 | +28.26% | 29 | Jul 30, 2026 | |
| HTFL HeartFlow | Initiated Coverage: Buy | $34 | $50.01 | -32.01% | 1 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $610 → $500 | $393.90 | +26.94% | 18 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $121 | $102.65 | +17.88% | 1 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $83 → $76 | $77.66 | -2.14% | 23 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $87 | $87.96 | -1.09% | 22 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $345 → $374 | $318.38 | +17.47% | 26 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $107.56 | n/a | 1 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $26 | $18.19 | n/a | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $22.02 | n/a | 1 | Dec 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $145 | $94.90 | n/a | 1 | Dec 21, 2021 |
Medtronic
Sep 2, 2026
Reiterated: Hold
Price Target: $85 → $100
Current: $92.80
Upside: +7.76%
Haemonetics
Aug 21, 2026
Reiterated: Buy
Price Target: $96 → $119
Current: $110.00
Upside: +8.19%
iRhythm Holdings
Aug 7, 2026
Reiterated: Buy
Price Target: $175 → $165
Current: $109.60
Upside: +50.55%
ResMed
Aug 7, 2026
Reiterated: Hold
Price Target: $225 → $213
Current: $226.57
Upside: -5.99%
PROCEPT BioRobotics
Aug 5, 2026
Reiterated: Hold
Price Target: $28 → $20
Current: $19.34
Upside: +3.41%
TransMedics Group
Aug 5, 2026
Reiterated: Buy
Price Target: $140 → $122
Current: $86.83
Upside: +40.50%
Inspire Medical Systems
Aug 4, 2026
Reiterated: Hold
Price Target: $50 → $59
Current: $75.69
Upside: -22.05%
Merit Medical Systems
Jul 31, 2026
Reiterated: Buy
Price Target: $83 → $98
Current: $85.52
Upside: +14.59%
Boston Scientific
Jul 30, 2026
Reiterated: Buy
Price Target: $70 → $56
Current: $43.66
Upside: +28.26%
HeartFlow
Jul 30, 2026
Initiated Coverage: Buy
Price Target: $34
Current: $50.01
Upside: -32.01%
Jul 17, 2026
Reiterated: Buy
Price Target: $610 → $500
Current: $393.90
Upside: +26.94%
Jun 30, 2026
Initiated Coverage: Buy
Price Target: $121
Current: $102.65
Upside: +17.88%
May 7, 2026
Reiterated: Buy
Price Target: $83 → $76
Current: $77.66
Upside: -2.14%
Apr 24, 2026
Reiterated: Hold
Price Target: $87
Current: $87.96
Upside: -1.09%
Jan 15, 2026
Downgraded: Hold
Price Target: $345 → $374
Current: $318.38
Upside: +17.47%
Apr 24, 2025
Reiterated: Hold
Price Target: n/a
Current: $107.56
Upside: n/a
Feb 28, 2023
Reiterated: Buy
Price Target: $17 → $26
Current: $18.19
Upside: n/a
Dec 21, 2021
Reiterated: Buy
Price Target: $75
Current: $22.02
Upside: n/a
Dec 21, 2021
Reiterated: Buy
Price Target: $145
Current: $94.90
Upside: n/a